Comparison of Speaking Valve Trial and Capping Trial for Tracheostomy Decannulation in Stroke Patients
ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorHongying Jiang, MD
About this trial
This study aims to compare the efficacy and safety of the Speaking Valve trial versus the traditional Capping trial as indicators for tracheostomy decannulation in stroke patients. The trial is a prospective, multicenter, randomized, parallel-group, outcomes-assessor-blinded study with an exploratory crossover design.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Passy-Muir Speaking Valve
- Tracheostomy tube capping
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Hongying Jiang, MD
Lead sponsor
Capital Medical University
Sponsor institution
Beijing Rehabilitation Hospital
Collaborator
Hunan Provincial Rehabilitation Hospital
Collaborator
Beijing Tiantan Hospital
Collaborator
Beijing Fengtai Rehabilitation Hospital
Collaborator
Source ClinicalTrials.gov